• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
SARS-CoV-2 variants with NSP12 P323L/G671S mutations display enhanced virus replication in ferret upper airways and higher transmissibility.带有 NSP12 P323L/G671S 突变的 SARS-CoV-2 变异株在雪貂上呼吸道中显示出增强的病毒复制能力和更高的传染性。
Cell Rep. 2023 Sep 26;42(9):113077. doi: 10.1016/j.celrep.2023.113077. Epub 2023 Sep 6.
2
SARS-CoV-2 variants show temperature-dependent enhanced polymerase activity in the upper respiratory tract and high transmissibility.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变体在上呼吸道表现出温度依赖性增强的聚合酶活性和高传播性。
bioRxiv. 2022 Sep 28:2022.09.27.509689. doi: 10.1101/2022.09.27.509689.
3
Biochemical characterization of naturally occurring mutations in SARS-CoV-2 RNA-dependent RNA polymerase.SARS-CoV-2 依赖 RNA 的 RNA 聚合酶中天然突变的生化特征。
Protein Sci. 2024 Sep;33(9):e5103. doi: 10.1002/pro.5103.
4
Point mutations at specific sites of the nsp12-nsp8 interface dramatically affect the RNA polymerization activity of SARS-CoV-2.特定部位的点突变显著影响 SARS-CoV-2 的 nsp12-nsp8 界面的 RNA 聚合酶活性。
Proc Natl Acad Sci U S A. 2024 Jul 16;121(29):e2317977121. doi: 10.1073/pnas.2317977121. Epub 2024 Jul 11.
5
In silico analysis of non-structural protein 12 sequences from SARS-COV-2 found in Manaus, Amazonas, Brazil, reveals mutations linked to higher transmissibility.对巴西亚马逊州玛瑙斯发现的 SARS-CoV-2 的非结构蛋白 12 序列进行计算机分析,揭示了与更高传染性相关的突变。
An Acad Bras Cienc. 2024 May 10;96(2):e20231336. doi: 10.1590/0001-3765202420231336. eCollection 2024.
6
Genetic conservation of SARS-CoV-2 RNA replication complex in globally circulating isolates and recently emerged variants from humans and minks suggests minimal pre-existing resistance to remdesivir.SARS-CoV-2 RNA 复制复合物在全球流行分离株和最近从人类和水貂中出现的变异株中的遗传保守性表明,瑞德西韦的预先存在的耐药性最小。
Antiviral Res. 2021 Apr;188:105033. doi: 10.1016/j.antiviral.2021.105033. Epub 2021 Feb 5.
7
Remdesivir MD Simulations Suggest a More Favourable Binding to SARS-CoV-2 RNA Dependent RNA Polymerase Mutant P323L Than Wild-Type.瑞德西韦 MD 模拟表明,与野生型相比,其对 SARS-CoV-2 RNA 依赖性 RNA 聚合酶突变体 P323L 的结合更有利。
Biomolecules. 2021 Jun 22;11(7):919. doi: 10.3390/biom11070919.
8
Analysis of the SARS-CoV-2 nsp12 P323L/A529V mutations: coeffect in the transiently peaking lineage C.36.3 on protein structure and response to treatment in Egyptian records.分析 SARS-CoV-2 nsp12 P323L/A529V 突变:在埃及记录中对 C.36.3 短暂高峰谱系的蛋白结构和治疗反应的共同影响。
Z Naturforsch C J Biosci. 2024 Jan 24;79(1-2):13-24. doi: 10.1515/znc-2023-0132. Print 2024 Jan 29.
9
Two conserved oligomer interfaces of NSP7 and NSP8 underpin the dynamic assembly of SARS-CoV-2 RdRP.两个保守的寡聚界面的 NSP7 和 NSP8 为 SARS-CoV-2 RdRP 的动态组装提供了基础。
Nucleic Acids Res. 2021 Jun 4;49(10):5956-5966. doi: 10.1093/nar/gkab370.
10
SARS-CoV-2 NSP12 associates with TRiC and the P323L substitution acts as a host adaption.SARS-CoV-2 NSP12 与 TRiC 结合,P323L 取代作为宿主适应。
J Virol. 2023 Nov 30;97(11):e0042423. doi: 10.1128/jvi.00424-23. Epub 2023 Nov 6.

引用本文的文献

1
The C-terminal Domain of SARS-CoV-2 nsp8 is a Molten Globule in the Absence of Binding Partners.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)非结构蛋白8(nsp8)的C末端结构域在没有结合伴侣的情况下是一种熔球态。
J Mol Biol. 2025 Aug 19;437(21):169400. doi: 10.1016/j.jmb.2025.169400.
2
A post-assembly conformational change makes the SARS-CoV-2 polymerase elongation-competent.组装后构象变化使新冠病毒聚合酶具备延伸能力。
Nucleic Acids Res. 2025 May 22;53(10). doi: 10.1093/nar/gkaf450.
3
Substitution-Mutation Rate Ratio (c/µ) As Molecular Adaptation Test Beyond Ka/Ks: A SARS-COV-2 Case Study.作为超越Ka/Ks的分子适应性测试的替换-突变率比(c/µ):一项新冠病毒(SARS-CoV-2)案例研究
J Mol Evol. 2025 May 3. doi: 10.1007/s00239-025-10248-6.
4
Enhanced RNA replication and pathogenesis in recent SARS-CoV-2 variants harboring the L260F mutation in NSP6.在NSP6中携带L260F突变的近期严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变体中增强的RNA复制和致病性。
PLoS Pathog. 2025 Mar 31;21(3):e1013020. doi: 10.1371/journal.ppat.1013020. eCollection 2025 Mar.
5
A Phylogenetic Method Identifies Candidate Drivers of the Evolution of the SARS-CoV-2 Mutation Spectrum.一种系统发育方法确定了SARS-CoV-2突变谱进化的候选驱动因素。
Mol Biol Evol. 2025 Apr 1;42(4). doi: 10.1093/molbev/msaf059.
6
A phylogenetic method identifies candidate drivers of the evolution of the SARS-CoV-2 mutation spectrum.一种系统发育方法确定了SARS-CoV-2突变谱进化的候选驱动因素。
bioRxiv. 2025 Jan 20:2025.01.17.633662. doi: 10.1101/2025.01.17.633662.
7
A comprehensive review of current insights into the virulence factors of SARS-CoV-2.对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)毒力因子当前见解的全面综述。
J Virol. 2025 Feb 25;99(2):e0204924. doi: 10.1128/jvi.02049-24. Epub 2025 Jan 29.
8
SARS-CoV-2 Evolution: Implications for Diagnosis, Treatment, Vaccine Effectiveness and Development.严重急性呼吸综合征冠状病毒2的进化:对诊断、治疗、疫苗有效性及研发的影响
Vaccines (Basel). 2024 Dec 28;13(1):17. doi: 10.3390/vaccines13010017.
9
The impact of remdesivir on SARS-CoV-2 evolution in vivo.瑞德西韦对体内严重急性呼吸综合征冠状病毒2(SARS-CoV-2)进化的影响。
JCI Insight. 2025 Jan 21;10(4):e182376. doi: 10.1172/jci.insight.182376.
10
A post-assembly conformational change makes the SARS-CoV-2 polymerase elongation-competent.组装后的构象变化使新冠病毒聚合酶具备延伸能力。
bioRxiv. 2025 Jan 10:2025.01.10.632299. doi: 10.1101/2025.01.10.632299.

本文引用的文献

1
A Rapid, Whole Genome Sequencing Assay for Detection and Characterization of Novel Coronavirus (SARS-CoV-2) Clinical Specimens Using Nanopore Sequencing.一种使用纳米孔测序对新型冠状病毒(SARS-CoV-2)临床样本进行检测和特征分析的快速全基因组测序检测方法。
Front Microbiol. 2022 Jun 6;13:910955. doi: 10.3389/fmicb.2022.910955. eCollection 2022.
2
Remdesivir and GS-441524 Retain Antiviral Activity against Delta, Omicron, and Other Emergent SARS-CoV-2 Variants.瑞德西韦和 GS-441524 对德尔塔、奥密克戎和其他新兴的 SARS-CoV-2 变体保持抗病毒活性。
Antimicrob Agents Chemother. 2022 Jun 21;66(6):e0022222. doi: 10.1128/aac.00222-22. Epub 2022 May 9.
3
The first three waves of the Covid-19 pandemic hint at a limited genetic repertoire for SARS-CoV-2.前三波新冠疫情表明,SARS-CoV-2 的基因库有限。
FEMS Microbiol Rev. 2022 May 6;46(3). doi: 10.1093/femsre/fuac003.
4
Age-dependent pathogenic characteristics of SARS-CoV-2 infection in ferrets.雪貂中 SARS-CoV-2 感染的年龄依赖性发病特征。
Nat Commun. 2022 Jan 10;13(1):21. doi: 10.1038/s41467-021-27717-3.
5
The short isoform of the host antiviral protein ZAP acts as an inhibitor of SARS-CoV-2 programmed ribosomal frameshifting.宿主抗病毒蛋白 ZAP 的短异构体可作为 SARS-CoV-2 程序性核糖体移码的抑制剂。
Nat Commun. 2021 Dec 10;12(1):7193. doi: 10.1038/s41467-021-27431-0.
6
Cloning of a Passage-Free SARS-CoV-2 Genome and Mutagenesis Using Red Recombination.无间隔 SARS-CoV-2 基因组的克隆和利用红色重组进行的诱变。
Int J Mol Sci. 2021 Sep 22;22(19):10188. doi: 10.3390/ijms221910188.
7
Clinical and Virological Features of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern: A Retrospective Cohort Study Comparing B.1.1.7 (Alpha), B.1.351 (Beta), and B.1.617.2 (Delta).关注的严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)变异株的临床和病毒学特征:比较 B.1.1.7(阿尔法)、B.1.351(贝塔)和 B.1.617.2(德尔塔)的回顾性队列研究。
Clin Infect Dis. 2022 Aug 24;75(1):e1128-e1136. doi: 10.1093/cid/ciab721.
8
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.Covid-19 疫苗对 B.1.617.2(德尔塔)变异株的有效性。
N Engl J Med. 2021 Aug 12;385(7):585-594. doi: 10.1056/NEJMoa2108891. Epub 2021 Jul 21.
9
Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization.德尔塔变异株对抗体中和的敏感性降低。
Nature. 2021 Aug;596(7871):276-280. doi: 10.1038/s41586-021-03777-9. Epub 2021 Jul 8.
10
Transient and stabilized complexes of Nsp7, Nsp8, and Nsp12 in SARS-CoV-2 replication.SARS-CoV-2 复制过程中 Nsp7、Nsp8 和 Nsp12 的瞬时和稳定复合物。
Biophys J. 2021 Aug 3;120(15):3152-3165. doi: 10.1016/j.bpj.2021.06.006. Epub 2021 Jun 29.

带有 NSP12 P323L/G671S 突变的 SARS-CoV-2 变异株在雪貂上呼吸道中显示出增强的病毒复制能力和更高的传染性。

SARS-CoV-2 variants with NSP12 P323L/G671S mutations display enhanced virus replication in ferret upper airways and higher transmissibility.

机构信息

Center for Study of Emerging and Re-emerging Viruses, Korea Virus Research Institute, Institute for Basic Science (IBS), Daejeon 34126, Republic of Korea.

College of Medicine and Medical Research Institute, Chungbuk National University, Cheongju 28644, Republic of Korea.

出版信息

Cell Rep. 2023 Sep 26;42(9):113077. doi: 10.1016/j.celrep.2023.113077. Epub 2023 Sep 6.

DOI:10.1016/j.celrep.2023.113077
PMID:37676771
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11550895/
Abstract

With the emergence of multiple predominant SARS-CoV-2 variants, it becomes important to have a comprehensive assessment of their viral fitness and transmissibility. Here, we demonstrate that natural temperature differences between the upper (33°C) and lower (37°C) respiratory tract have profound effects on SARS-CoV-2 replication and transmissibility. Specifically, SARS-CoV-2 variants containing the NSP12 mutations P323L or P323L/G671S exhibit enhanced RNA-dependent RNA polymerase (RdRp) activity at 33°C compared with 37°C and high transmissibility. Molecular dynamics simulations and microscale thermophoresis demonstrate that the NSP12 P323L and P323L/G671S mutations stabilize the NSP12-NSP7-NSP8 complex through hydrophobic effects, leading to increased viral RdRp activity. Furthermore, competitive transmissibility assay reveals that reverse genetic (RG)-P323L or RG-P323L/G671S NSP12 outcompetes RG-WT (wild-type) NSP12 for replication in the upper respiratory tract, allowing markedly rapid transmissibility. This suggests that NSP12 P323L or P323L/G671S mutation of SARS-CoV-2 is associated with increased RdRp complex stability and enzymatic activity, promoting efficient transmissibility.

摘要

随着多种主要 SARS-CoV-2 变体的出现,全面评估它们的病毒适应性和传染性变得尤为重要。在这里,我们证明了上呼吸道(33°C)和下呼吸道(37°C)之间的自然温差对 SARS-CoV-2 的复制和传染性有深远的影响。具体来说,与 37°C 相比,含有 NSP12 突变 P323L 或 P323L/G671S 的 SARS-CoV-2 变体在 33°C 下表现出增强的 RNA 依赖性 RNA 聚合酶(RdRp)活性和高传染性。分子动力学模拟和微尺度热泳分析表明,NSP12 的 P323L 和 P323L/G671S 突变通过疏水作用稳定 NSP12-NSP7-NSP8 复合物,从而提高病毒 RdRp 活性。此外,竞争性传染性测定表明,反向遗传学(RG)-P323L 或 RG-P323L/G671S NSP12 在复制过程中比 RG-WT(野生型)NSP12 在上呼吸道更具竞争力,从而允许更快的传播速度。这表明 SARS-CoV-2 的 NSP12 P323L 或 P323L/G671S 突变与 RdRp 复合物稳定性和酶活性的增加有关,从而促进了有效的传染性。